Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stevo Julius

Showing results (101-110 of 104) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 104 results.
Hypertension (Dallas, Tex. : 1979)|March 26, 2005
Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophyFrej Fyhrquist, Björn Dahlöf, Richard B Devereux, et al.
Hypertension (Dallas, Tex. : 1979)|December 8, 2004
Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension studyJorge R Kizer, Björn Dahlöf, Sverre E Kjeldsen, et al.
Journal of Hypertension|August 27, 2002
Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension studyLars H Lindholm, Hans Ibsen, Knut Borch-Johnsen, et al.
Annals of Internal Medicine|December 4, 2003
Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE studyKristian Wachtell, Hans Ibsen, Michael H Olsen, et al.
Pageof 11

Showing results (101-110 of 104) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 104 results.
Hypertension (Dallas, Tex. : 1979)|March 26, 2005
Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophyFrej Fyhrquist, Björn Dahlöf, Richard B Devereux, et al.
Hypertension (Dallas, Tex. : 1979)|December 8, 2004
Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension studyJorge R Kizer, Björn Dahlöf, Sverre E Kjeldsen, et al.
Journal of Hypertension|August 27, 2002
Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension studyLars H Lindholm, Hans Ibsen, Knut Borch-Johnsen, et al.
Annals of Internal Medicine|December 4, 2003
Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE studyKristian Wachtell, Hans Ibsen, Michael H Olsen, et al.
Pageof 11